NCT05909137View on ClinicalTrials.gov

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2026

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

ImmunotherapyIntensity Modulated Radiation TherapyRadiotherapyNSCLC

Interventions

RADIATION

IMRT+adjuvant immunotherapy

The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT and the control group with CTV-delineated IMRT using a random number table.

All Listed Sponsors

lead

Xinqiao Hospital of Chongqing

OTHER